Statement from Pfizer Chairman and CEO Albert Bourla on Testing Positive for COVID-19
Pfizer
AUGUST 15, 2022
In preclinical studies, nirmatrelvir did not demonstrate evidence of mutagenic DNA interactions. Cystic fibrosis transmembrane conductance regulator potentiators: lumacaftor/ivacaftor. A transient decrease in body weight was observed in the nursing offspring of rats administered nirmatrelvir. anti-infectives).
Let's personalize your content